INNV (InnovAge Holding) ROCE %: -31.36% (As of Mar. 2026)


INNV InnovAge Holding Corp INNV
71 GF Score
Price $10.55
GF Value $6.52
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is InnovAge Holding ROCE %?

InnovAge Holding INNV +1.88% 71 ROCE % is -31.36% as of Mar. 2026. GuruFocus rates INNV with a GF Score™ of 71/100 and a GF Value™ of $6.52 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. InnovAge Holding's annualized ROCE % for the quarter that ended in Mar. 2026 was -31.36%.

InnovAge Holding  (NAS:INNV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

InnovAge Holding ROCE % Related Terms

InnovAge Holding ROCE % Historical Data

* Premium members only.

The historical data trend for InnovAge Holding's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnovAge Holding ROCE % Chart

InnovAge Holding Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial -4.63 -1.04 -11.34 -4.30 -7.63

InnovAge Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.46 -3.93 9.99 14.53 -31.36
INNV
71GF Score
InnovAge Holding Corp INNV
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InnovAge Holding ROCE % Calculation

InnovAge Holding's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-29.415/( ( (547.661 - 138.599) + (526.851 - 164.807) )/ 2 )
=-29.415/( (409.062+362.044)/ 2 )
=-29.415/385.553
=-7.63 %

InnovAge Holding's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-115.14/( ( (527.482 - 144.702) + (547.394 - 195.888) )/ 2 )
=-115.14/( ( 382.78 + 351.506 )/ 2 )
=-115.14/367.143
=-31.36 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -31.36% mean?
InnovAge Holding (INNV) has a ROCE % of -31.36% as of Mar. 2026.
Is InnovAge Holding's ROCE % too high?
InnovAge Holding's current ROCE % is -31.36%. Overall, InnovAge Holding has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnovAge Holding's ROCE % compare to USPH and AMN?
InnovAge Holding's ROCE % of -31.36% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnovAge Holding's current ROCE % is -31.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovAge Holding stock overvalued right now?
Based on GuruFocus' analysis, InnovAge Holding (INNV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.52, compared to a current price of $10.55 — trading 61.8% above its estimated fair value. The current ROCE % is -31.36%. InnovAge Holding's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For InnovAge Holding (INNV), the current ROCE % is -31.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InnovAge Holding (INNV) Overvalued in 2026?

Based on GuruFocus' analysis, InnovAge Holding stock appears to be overvalued. The current stock price of $10.55 is trading 61.8% above its estimated GF Value™ of $6.52. GuruFocus considers InnovAge Holding to be Significantly Overvalued.

Key valuation signals for INNV:

  • ROCE %: -31.36%
  • GF Value™: $6.52 vs. price of $10.55 (61.8% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the INNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InnovAge Holding Business Description

Address 8950 East Lowry Boulevard, Denver, CO, USA, 80230
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
71GF Score

Get the complete analysis for INNV

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.55
Price
$6.52
GF Value